LAMBRIS JOHN D has a total of 16 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ANCHOR THERAPEUTICS INC, NORTHSTAR BIOLOG PTY LTD and PANTHERYX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Lambris John D | 16 |
#2 | Markiewski Maciej M | 2 |
#3 | Ritis Konstantinos | 2 |
#4 | Qu Hongchang | 2 |
#5 | Connolly Jr E Sander | 1 |
#6 | Taylor Fletcher B | 1 |
#7 | Korsgren Olie | 1 |
#8 | Nillson Bo | 1 |
#9 | Ricklin Daniel | 1 |
#10 | Nadeau Joseph | 1 |
Publication | Filing date | Title |
---|---|---|
US2013344592A1 | Factor H binding peptides and uses thereof | |
US2013053302A1 | Treatment of sepsis using complement inhibitors | |
US2012178694A1 | Modified compstatin with peptide backbone and C-terminal modifications | |
US2011060127A1 | Structure of compstatin-C3 complex and use for rational drug design | |
US2011008343A1 | Method Of Reducing Tissue Loss In Pancreatic Islet Cell Transplantation | |
US2011046075A1 | Secreted Staphylococcus Aureus Proteins And Peptides For Use In Inhibiting Activation Of The Complement System |